GS
Gilead Sciences Portfolio holdings
AUM
$1.94B
1-Year Est. Return
59.93%
This Fund
S&P 500
1 Year Est. Return
+59.93%
AUM
$1.79B
AUM Growth
+$511M
(+40%)
Holding
14
Top Sells
| 1 | +$2.35M | |
| 2 | +$1.31M | |
| 3 | +$848K | |
| 4 |
IMA
ImageneBio Inc
IMA
|
+$467K |
| 5 |
BRNS
Barinthus Biotherapeutics
BRNS
|
+$92.5K |
Sector Composition
| 1 | Healthcare | 99.87% |
| 2 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Galapagos
GLPG
$2.19B
| $579M | 32.31% |
16,707,477
|
|
||
2
Arcellx
ACLX
$6.7B
| $552M | 30.8% |
6,720,803
|
|
||
3
Arcus Biosciences
RCUS
$2.83B
| $427M | 23.86% |
31,424,760
|
|
||
4
Assembly Biosciences
ASMB
$451M
| $115M | 6.44% |
4,505,391
+2,295,920
|
|
||
|
MRUS
5
DELISTED
Merus
MRUS
| $42.6M | 2.38% |
452,527
|
|
||
6
Tango Therapeutics
TNGX
$2.67B
| $40.8M | 2.28% |
4,854,443
|
|
||
7
Kyverna Therapeutics
KYTX
$525M
| $24.8M | 1.38% |
4,126,119
|
|
||
8
Xilio Therapeutics
XLO
$39M
| $7.67M | 0.43% |
9,105,451
|
|
||
|
CYPH
9
Cypherpunk Technologies Inc
CYPH
$45M
| $2.41M | 0.13% |
5,319,148
|
|
||
10
Allogene Therapeutics
ALLO
$510M
| – | – |
-1,156,689
|
|
||
|
BRNS
11
Barinthus Biotherapeutics
BRNS
$27.8M
| – | – |
-99,478
|
|
||
|
HOOK
12
DELISTED
HOOKIPA Pharma
HOOK
| – | – |
-1,875,945
|
|
||
|
IMA
13
ImageneBio Inc
IMA
$67.3M
| – | – |
-29,045
|
|
||
|
KLRS
14
Kalaris Therapeutics
KLRS
$159M
| – | – |
-317,789
|
|